financial_disclosure

Kingsville, ON – September 04, 2026 -- Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) reported net revenue of CA$2.23 million for the three months ended June 30, 2026, up 38% from CA$1.62 million a year earlier, while grams sold hit a record 2.33 million, an 8% increase over the prior high.

Cash cost per gram falls 30% to CA$0.69 as production efficiency improves

The company generated CA$36,778 in cash from operating activities, reversing a cash outflow of CA$865,538 in the same quarter last year. Adjusted EBITDA came in positive at CA$47,900, even as net loss and comprehensive loss totaled CA$659,893. Gross margin before fair value adjustments narrowed to 12%, reflecting a lower average net sales price of CA$0.96 per gram, or CA$1.30 per gram excluding inventory tied to discontinued cultivars.

Sydney – September 04, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has closed an oversubscribed, tranched public offering that generated approximately $40 million in upfront gross proceeds, with total potential proceeds reaching approximately $120 million if milestone-linked warrants are fully exercised.

Offering priced above market with milestone-triggered warrant premiums

The combined offering price was set at $15.50 per American Depositary Share (ADS), with both warrant tranches priced at premiums to that level. Series A Warrants carry an exercise price of $17.825 per ADS, a 15% premium, tied to Kazia's Stage IV triple-negative breast cancer (TNBC) data readout expected in the second half of 2027. Series B Warrants carry an exercise price of $19.375 per ADS, a 25% premium, tied to the company's HR+/HER2- breast cancer data readout expected in the first half of 2028.

Dallas – September 04, 2026 -- Cango Inc. (NYSE: CANG) reported a net loss of US$81.6 million for the second quarter of 2026, driven primarily by non-cash impairment and disposal charges on its Bitcoin mining fleet, as the company accelerates a pivot toward AI compute infrastructure.

Revenue halves as company right-sizes mining fleet

Total revenue fell approximately 50% sequentially to US$50.8 million, with US$47.4 million derived from Bitcoin mining and US$3.4 million from other sources. The decline stemmed from Cango's decision to phase out older S19-series mining machines and shift some capacity to a hosted leasing model, a move management said improved operating costs and cash flow despite the top-line hit.

Herzliya, Israel – September 04, 2026 -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) reported second-quarter fiscal 2026 revenue of US$5.25 million (CAD 7.3 million), a 25.06% decline from US$7.01 million in the same period last year, as shifting U.S. customs and tariff policy under the Trump administration disrupted sales.

Gross margin holds above 90% despite revenue drop

Gross profit fell 23.0% to US$4.769 million, but gross margin remained elevated at 90.8% for the three months ended June 30, 2026, up from 88.4% a year earlier. The company attributed the resilience to its direct-to-consumer model and disciplined cost structure at consumer wellness subsidiary B.I. Sky Global Ltd., which it owns 60%.

INDIANAPOLIS – September 03, 2026 -- Eli Lilly and Company reported that combining Taltz (ixekizumab) with Zepbound (tirzepatide) sustained or deepened efficacy at 52 weeks in patients with psoriatic disease and obesity, building on statistically superior results already seen at Week 36 versus Taltz alone.

Combination therapy nearly triples complete skin clearance response rates

In the TOGETHER-PsO trial, 30.6% of patients on the combination achieved PASI 100 plus at least 10% weight loss at Week 52, compared with 4.4% on Taltz monotherapy. Complete skin clearance alone (PASI 100) was maintained by 40.5% of combination patients versus 29.1% on monotherapy.

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) combined with chemotherapy produced a statistically significant and clinically meaningful overall survival (OS) benefit versus trastuzumab plus chemotherapy in a second interim analysis of the Phase 3 HERIZON-GEA-01 trial in first-line HER2-positive gastroesophageal adenocarcinoma (GEA).

OS hazard ratio for Ziihera plus chemotherapy improved versus the first interim analysis

The company said the survival advantage strengthened compared with earlier data, reinforcing Ziihera's position following its FDA approval on August 25, 2026. No new safety signals emerged relative to previously reported HERIZON-GEA-01 data or the known profiles of the individual agents.

PITTSBURGH – September 03, 2026 -- Jennmar has secured a five-year exclusive contract to supply ground support products to Outokumpu's Kemi mine, Finland's largest underground mine and the only operating chrome mine in Europe.

Jennmar creates dedicated Finnish entity to service the contract

The company has established Jennmar Finland, a new subsidiary tasked with streamlining commercial transactions for Outokumpu and the mine's leadership teams. The multi-year agreement covers roof anchors, cable anchors, mesh, steel accessories and injectable resins tailored to the underground conditions at Kemi.

VANCOUVER – September 03, 2026 -- Defense Metals Corp. (TSXV: DEFN) (OTCQB: DFMTF) (FSE:35D) has reported assay results from an initial eleven core drill holes totaling 1,633 metres at its 100%-owned Wicheeda Rare Earth Project near Prince George, British Columbia, with drill hole WI26-96 returning 2.86% Total Rare Earth Oxide (TREO) over 65 metres, including a higher-grade section averaging 6.15% TREO over 20.3 metres.

Drill hole WI26-93 delivers 1.70% TREO over 184 metres at the deposit's southern margin

Collared from the same setup as WI26-96, hole WI26-93 cut obliquely across the southern margin of the Wicheeda Deposit, intersecting mixed xenolithic and dolomite carbonatite grading 1.70% TREO over 184 metres, including 2.52% TREO over 57 metres.

Houston – September 03, 2026 -- Summit Midstream Corporation (NYSE: SMC) has reached a final investment decision on a mainline compression expansion for its Double E Pipeline, backed by a new 200 MMcf/d long-term firm transportation agreement with an investment-grade shipper.

Open season secures 550 MMcf/d of new take-or-pay commitments

Double E Pipeline, LLC concluded an open season that generated 550 MMcf/d of binding long-term commitments, pushing total contracted firm capacity on the system to approximately 2.2 Bcf/d. The expansion will add a bi-directional mainline compressor station that increases forward haul capacity to the Waha Hub by roughly 900 MMcf/d, with an in-service target of the fourth quarter of 2028. Double E has already placed a purchase order for the long-lead gas turbine compression units to lock in manufacturing slots, though the project still requires FERC and other regulatory approvals.

HONG KONG – September 03, 2026 -- TCL Electronics Holdings Limited (01070.HK) reported adjusted profit attributable to shareholders of HKD 1.64 billion for the first half of 2026, up 54.3% year-on-year, as revenue climbed 16.4% to HKD 63.76 billion.

Gross profit rose 30.3% to HKD 10.90 billion, while net profit after tax reached HKD 1.62 billion. Annualized return on equity improved 4.2 percentage points to 16.5%. Overall expense ratio was held at 11.7% of revenue, which the company attributed to AI-driven operational efficiency and scale economies.